RxDoctor Payments Data

Tammy Wall, PA

Physician Assistant · Corpus Christi, TXNPI 1245348358

Payments from drug & device makers

$3,946in general payments, 2019–2025

Across 278 payments — averaging $14.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$836
  • Lilly USA, LLC$703
  • AbbVie$633
  • Pfizer$296
  • GSK$226
  • Merck$132
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,90699%
  • Education$401%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,946 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$32,107
Medicare patients
126
Services billed
669

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide90$111,224
OzempicSemaglutide60$56,451
EliquisApixaban32$26,695
JardianceEmpagliflozin19$22,308
FarxigaDapagliflozin Propanediol19$15,360
RybelsusSemaglutide11$10,496
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$9,717
Repatha SureclickEvolocumab16$9,026
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,374
Omeprazole183$2,222
Metoprolol Succinate85$1,370
Atorvastatin Calcium194$1,265
Levothyroxine Sodium127$1,030
Losartan Potassium136$1,028
Gabapentin67$1,000

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$703$111,22490 claims
Novo NordiskOzempic, Rybelsus$836$66,94771 claims
PfizerEliquis$296$26,69532 claims
Boehringer IngelheimJardiance$112$22,30819 claims
AstraZenecaFarxiga$18$15,36019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →